共 119 条
[1]
Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108
[2]
Bray F(2016)Bladder cancer Lancet 388 2796-2810
[3]
Siegel RL(2000)Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder Cancer: results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 18 3068-3077
[4]
Ferlay J(2017)Pembrolizumab as second-line therapy for advanced urothelial carcinoma N Engl J Med 376 1015-1026
[5]
Lortet-Tieulent J(2015)GHSR hypermethylation: a promising pan-cancer marker Cell Cycle 14 689-690
[6]
Jemal A(2013)Emerging targeted agents in metastatic breast cancer Nat Rev Clin Oncol 10 191-210
[7]
Kamat AM(2014)Comprehensive molecular characterization of urothelial bladder carcinoma Nature 507 315-322
[8]
Hahn NM(2013)Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder Cancer J Clin Oncol 31 3133-3140
[9]
Efstathiou JA(2014)Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy Mod Pathol Off J US Can Acad Pathol Inc 27 271-280
[10]
Lerner SP(2015)Harnessing connectivity in a large-scale small-molecule sensitivity dataset Cancer Discov 5 1210-1223